These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33995658)

  • 1. KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.
    Liu W; Zhan Z; Zhang M; Sun B; Shi Q; Luo F; Zhang M; Zhang W; Hou Y; Xiao X; Li Y; Feng H
    Theranostics; 2021; 11(13):6278-6292. PubMed ID: 33995658
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.
    Yu B; Luo F; Sun B; Liu W; Shi Q; Cheng SY; Chen C; Chen G; Li Y; Feng H
    Adv Sci (Weinh); 2021 Oct; 8(20):e2100014. PubMed ID: 34392614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.
    Lv D; Jia F; Hou Y; Sang Y; Alvarez AA; Zhang W; Gao WQ; Hu B; Cheng SY; Ge J; Li Y; Feng H
    Cancer Res; 2017 Nov; 77(22):6190-6201. PubMed ID: 29021135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.
    Simó-Riudalbas L; Pérez-Salvia M; Setien F; Villanueva A; Moutinho C; Martínez-Cardús A; Moran S; Berdasco M; Gomez A; Vidal E; Soler M; Heyn H; Vaquero A; de la Torre C; Barceló-Batllori S; Vidal A; Roz L; Pastorino U; Szakszon K; Borck G; Moura CS; Carneiro F; Zondervan I; Savola S; Iwakawa R; Kohno T; Yokota J; Esteller M
    Cancer Res; 2015 Sep; 75(18):3936-45. PubMed ID: 26208904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression.
    Zhao W; Mo H; Liu R; Chen T; Yang N; Liu Z
    Br J Cancer; 2022 Jul; 127(2):202-210. PubMed ID: 35332266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
    Liu HR; Zhao J
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.
    Deng Q; Hou J; Feng L; Lv A; Ke X; Liang H; Wang F; Zhang K; Chen K; Cui H
    Cell Death Dis; 2018 Oct; 9(11):1049. PubMed ID: 30323224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.
    Xu C; Liu F; Xiang G; Cao L; Wang S; Liu J; Meng Q; Xu D; Lv S; Jiao J; Niu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):238. PubMed ID: 31171012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway.
    Hu W; Li M; Chen Y; Gu X
    J Ovarian Res; 2021 Sep; 14(1):121. PubMed ID: 34535173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.
    Wiesel-Motiuk N; Assaraf YG
    Drug Resist Updat; 2020 Dec; 53():100729. PubMed ID: 33130515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
    Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S
    Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
    Wang G; Li L; Li Y; Zhang LH
    Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation.
    Wang Z; Sun A; Yan A; Yao J; Huang H; Gao Z; Han T; Gu J; Li N; Wu H; Li K
    Mol Cancer; 2022 Apr; 21(1):92. PubMed ID: 35366893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
    Wang X; Zhao H; Wang P; Zhang J; Li N; Liu Y; Zhang F; Yu Y
    Anticancer Drugs; 2022 Nov; 33(10):989-998. PubMed ID: 36206129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.
    Baell JB; Leaver DJ; Hermans SJ; Kelly GL; Brennan MS; Downer NL; Nguyen N; Wichmann J; McRae HM; Yang Y; Cleary B; Lagiakos HR; Mieruszynski S; Pacini G; Vanyai HK; Bergamasco MI; May RE; Davey BK; Morgan KJ; Sealey AJ; Wang B; Zamudio N; Wilcox S; Garnham AL; Sheikh BN; Aubrey BJ; Doggett K; Chung MC; de Silva M; Bentley J; Pilling P; Hattarki M; Dolezal O; Dennis ML; Falk H; Ren B; Charman SA; White KL; Rautela J; Newbold A; Hawkins ED; Johnstone RW; Huntington ND; Peat TS; Heath JK; Strasser A; Parker MW; Smyth GK; Street IP; Monahan BJ; Voss AK; Thomas T
    Nature; 2018 Aug; 560(7717):253-257. PubMed ID: 30069049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.